Johnson & Johnson is investing more than $2 billion to build a state-of-the-art biologics manufacturing facility in Wilson, NC. The new facility will expand production of the company’s portfolio and pipeline of biologics in support of J&J’s aim to advance more than 70 therapy and product expansion filings and launches by the end of the decade.   The new facility will expand production of biologics in areas including oncology, immunology, and neuroscience, with the latest technology foc...